Tamil NaduWednesday, 26 August 2026·Hindu Tamil Thisai
Tamil Nadu to act on free Emicizumab for Hemophilia-A patients
The Health Minister said Tamil Nadu is taking steps to provide Emicizumab for Hemophilia-A patients, noting it is not yet in the National Health Mission essential medicines list.
Key highlights
Direct fact
In August 2026, Tamil Nadu Health Minister K.G. Arunraj told the Assembly that steps are being taken to provide Emicizumab for Hemophilia-A patients, after an MLA asked whether the drug would be given free of cost in Tamil Nadu.
Key specifics
- Emicizumab is used for treating Hemophilia-A patients.
- The drug has not been included by the Government of India in the National Health Mission essential medicines list.
- The issue was raised in the Tamil Nadu Assembly by TVK MLA M.S. Ravi.
- The minister said the government is considering action because the drug helps prevent bleeding.
- The announcement was made in August 2026 in Chennai.
Exam lens
TNPSC health-policy question type: identify the disease, the drug name, the minister, and the NHM essential medicines list; a likely one-liner is “Which drug is being considered for free supply to Hemophilia-A patients in Tamil Nadu?”